Clinical trial / 2000
Black currant anthocyanosides significantly lowered dark adaptation thresholds and improved visual fatigue symptoms in healthy humans.
In a double-blind, placebo-controlled crossover study, healthy humans were given black currant anthocyanosides (BCA) concentrate. BCA intake at three doses (12.5, 20, and 50 mg, n=12) appeared to dose-dependently lower the dark adaptation threshold, with a significant difference before vs. after intake at the 50 mg dose (p = 0.011). In a visual display terminal task (n=21), 50 mg BCA prevented a decrease in refraction values of the dominant eye compared to placebo (p = 0.064). Questionnaire assessment showed significant improvement in subjective asthenopia symptoms concerning the eye and lower back after BCA intake.
- Study type
- Double-blind, placebo-controlled crossover study
- Who was studied
- Healthy human subjects (n=12 in dark adaptation test; n=21 in refraction test)
- What was measured
- Dark adaptation threshold, transient refractive alteration, visual fatigue
THE PAPER
Effects of black current anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans.
Nakaishi H, Matsumoto H, Tominaga S, Hirayama M. Altern Med Rev, 2000.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.